This year, CPhI Worldwide, ICSE and P-MEC conferences in Madrid, Spain were co-hosted with a new show, BioPh, that focused on the biologics and biopharmaceutical manufacturing sector.
The event attracted a varied range of exhibitors with specialist contract manufacturing organisations (CMO) sitting side by side with dedicated big pharma units and national delegations.
in-Pharmatechnologist spoke with some with key players OctoPlus, Glycotope, Merck and SCM Pharma who shared their responses to BioPh and how well it worked in combination with the wider conferences’ focus on traditional small-molecule drug manufacturing.